Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Ashwani Gujral of ashwanigujral.com recommends buying HDIL and advises selling Indiabulls Housing Finance and Eicher Motors.
Sandeep Wagle of powermywealth.com recommends buying Oil and Natural Gas Corporation, Lupin and HDIL.
Ashwani Gujral of ashwanigujral.com recommends selling Zee Entertainment and United Spirits and buy HDIL.
Kunal Saraogi of Equityrush advises buy HDIL with a target of Rs 90.
Navneet Daga of IIFL recommends shorting Bank of Baroda as the stock may head lower.
Ashwani Gujral of ashwanigujral.com recommends buying Bharti Airtel, HDIL and Ajanta Pharma.
Ashwani Gujral of ashwanigujral.com advises buying Shriram Transport Finance Corporation, Indiabulls Housing Finance and Petronet LNG.
Ashwani Gujral of ashwanigujral.com recommends buying Britannia Industries, HDIL and Rashtriya Chemicals and Fertilisers.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy HDIL and Eicher Motors and advises selling Syndicate Bank.
Shahina Mukadam, Independent Market Expert is of the view that one may buy DLF with a target of Rs 127.
Krish Subramanyam of Altamount Capital is of the view that one can sell Arvind May futures and also sell 270 Put.
Prakash Gaba of prakashgaba.com recommends going long in United Spirits and feels that Cairn India may hit Rs 132 while HDIL may test Rs 75.
Manish Sharma of derivativetradingresearch is of the view that one may buy Petronet LNG with a target of Rs 280.
Manish Sharma of derivativetradingresearch advises buying Sun TV with a target of Rs 378.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com spoke about his outlook on the market and specific stocks.
Ashwani Gujral of ashwanigujral.com recommends buying HDIL, Ceat and Indiabulls Real Estate.
Ashwani Gujral of ashwanigujral.com recommends buying Glenmark Pharma and advises selling IRB Infra and HDIL.
Krish Subramanyam of Altamount Capital advises buying NIIT with a target of Rs 87.
Ashwani Gujral of ashwanigujral.com recommends buying HDIL, BPCL and Syndicate Bank.
Sandeep Wagle of powermywealth.com recommends buying HDIL, Amara Raja Batteries, TVS Motor and Petronet LNG.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy DLF and HDIL.
Sandeep Wagle of powermywealth.com is of the view that one can buy HDIL and TVS Motor Company.
Gaurav Ratnaparkhi of Sharekhan recommends buying Reliance Communications with a target of Rs 53.40 and KPIT Technologies with a target of Rs 155.80.
Vishal Malkan of malkansview.com recommends buying Reliance Communications with a target of Rs 55 and Bata India with a target of Rs 540.
Rajat Bose of rajatkbose.com is of the view that one may buy ICICI Bank and sell Aurobindo Pharma.